151 related articles for article (PubMed ID: 8993241)
1. Preoperative platelet dysfunction increases the benefit of aprotinin in cardiopulmonary bypass.
Ray MJ; Marsh NA; Just SJ; Perrin EJ; O'Brien MF; Hawson GA
Ann Thorac Surg; 1997 Jan; 63(1):57-63. PubMed ID: 8993241
[TBL] [Abstract][Full Text] [Related]
2. Platelet protection by low-dose aprotinin in cardiopulmonary bypass: electron microscopic study.
Lavee J; Raviv Z; Smolinsky A; Savion N; Varon D; Goor DA; Mohr R
Ann Thorac Surg; 1993 Jan; 55(1):114-9. PubMed ID: 7678061
[TBL] [Abstract][Full Text] [Related]
3. Aprotinin prevents cardiopulmonary bypass-induced platelet dysfunction. A scanning electron microscope study.
Mohr R; Goor DA; Lusky A; Lavee J
Circulation; 1992 Nov; 86(5 Suppl):II405-9. PubMed ID: 1385010
[TBL] [Abstract][Full Text] [Related]
4. Platelet composition and function in patients undergoing cardiopulmonary bypass for heart surgery.
Bertolino G; Locatelli A; Noris P; Maurelli M; Ceriana P; Mazzini G; Spedini P; Belletti S; Balduini CL
Haematologica; 1996; 81(2):116-20. PubMed ID: 8641638
[TBL] [Abstract][Full Text] [Related]
5. Aprotinin in pediatric cardiac operations: platelet function, blood loss, and use of homologous blood.
Boldt J; Knothe C; Zickmann B; Wege N; Dapper F; Hempelmann G
Ann Thorac Surg; 1993 Jun; 55(6):1460-6. PubMed ID: 7685588
[TBL] [Abstract][Full Text] [Related]
6. Platelet function during cardiac surgery and cardiopulmonary bypass with low-dose aprotinin.
Basora M; Gomar C; Escolar G; Pacheco M; Fita G; Rodriguez E; Ordinas A
J Cardiothorac Vasc Anesth; 1999 Aug; 13(4):382-7. PubMed ID: 10468248
[TBL] [Abstract][Full Text] [Related]
7. Platelet protection by aprotinin in cardiopulmonary bypass: electron microscopic study.
Lavee J; Savion N; Smolinsky A; Goor DA; Mohr R
Ann Thorac Surg; 1992 Mar; 53(3):477-81. PubMed ID: 1371665
[TBL] [Abstract][Full Text] [Related]
8. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double-blind placebo-controlled study.
Casas JI; Zuazu-Jausoro I; Mateo J; Oliver A; Litvan H; Muñiz-Díaz E; Arís A; Caralps JM; Fontcuberta J
J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 1):1107-17. PubMed ID: 7475139
[TBL] [Abstract][Full Text] [Related]
9. Aprotinin modulation of platelet activation in patients undergoing cardiopulmonary bypass operations.
Primack C; Walenga JM; Koza MJ; Shankey TV; Pifarre R
Ann Thorac Surg; 1996 Apr; 61(4):1188-93. PubMed ID: 8607681
[TBL] [Abstract][Full Text] [Related]
10. The influence of aprotinin and tranexamic acid on platelet function and postoperative blood loss in cardiac surgery.
Mengistu AM; Röhm KD; Boldt J; Mayer J; Suttner SW; Piper SN
Anesth Analg; 2008 Aug; 107(2):391-7. PubMed ID: 18633013
[TBL] [Abstract][Full Text] [Related]
11. Aprotinin preserves hemostasis in aspirin-treated patients undergoing cardiopulmonary bypass.
Tabuchi N; Huet RC; Sturk A; Eijsman L; Wildevuur CR
Ann Thorac Surg; 1994 Oct; 58(4):1036-9. PubMed ID: 7524460
[TBL] [Abstract][Full Text] [Related]
12. Aprotinin reduces cardiopulmonary bypass-induced blood loss and inhibits fibrinolysis without influencing platelets.
Orchard MA; Goodchild CS; Prentice CR; Davies JA; Benoit SE; Creighton-Kemsford LJ; Gaffney PJ; Michelson AD
Br J Haematol; 1993 Nov; 85(3):533-41. PubMed ID: 7510990
[TBL] [Abstract][Full Text] [Related]
13. Aprotinin reduces blood loss after cardiopulmonary bypass by direct inhibition of plasmin.
Ray MJ; Marsh NA
Thromb Haemost; 1997 Sep; 78(3):1021-6. PubMed ID: 9308747
[TBL] [Abstract][Full Text] [Related]
14. A single dose of aprotinin prevents platelet hyporeactivity after coronary artery bypass graft surgery.
Szczeklik W; Morawski W; Sanak M; Jakieła B; Bolkowski M; Cisowski M; Szczeklik M; Bochenek A; Musiał J
Pol Arch Med Wewn; 2010 Sep; 120(9):321-7. PubMed ID: 20864904
[TBL] [Abstract][Full Text] [Related]
15. Cardiac surgery with cardiopulmonary bypass: does aprotinin affect outcome?
Van der Linden PJ; Hardy JF; Daper A; Trenchant A; De Hert SG
Br J Anaesth; 2007 Nov; 99(5):646-52. PubMed ID: 17855736
[TBL] [Abstract][Full Text] [Related]
16. Platelet function during cardiopulmonary bypass not changed by two different doses of aprotinin.
Santamaría A; Mateo J; Muñíz-Díaz E; Oliver A; Murillo J; Litvan H; Souto JC; Fontcuberta J
Haematologica; 2000 Apr; 85(4):381-5. PubMed ID: 10756363
[TBL] [Abstract][Full Text] [Related]
17. Aprotinin has no effect on platelet activation and adhesion during cardiopulmonary bypass.
Wahba A; Black G; Koksch M; Rothe G; Preuner J; Schmitz G; Birnbaum DE
Thromb Haemost; 1996 May; 75(5):844-8. PubMed ID: 8725734
[TBL] [Abstract][Full Text] [Related]
18. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass.
Blauhut B; Gross C; Necek S; Doran JE; Späth P; Lundsgaard-Hansen P
J Thorac Cardiovasc Surg; 1991 Jun; 101(6):958-67. PubMed ID: 1710008
[TBL] [Abstract][Full Text] [Related]
19. Effect of aprotinin on plasma fibronectin levels during cardiopulmonary bypass.
al Khudhairi DM; Nadeem F; Zuleika AM; Hussain A; Ahmed A; el Sharkawy M
Ann Thorac Surg; 1997 Jan; 63(1):64-7. PubMed ID: 8993242
[TBL] [Abstract][Full Text] [Related]
20. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass.
van Oeveren W; Harder MP; Roozendaal KJ; Eijsman L; Wildevuur CR
J Thorac Cardiovasc Surg; 1990 May; 99(5):788-96; discussion 796-7. PubMed ID: 1691806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
